Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253443458> ?p ?o ?g. }
- W4253443458 abstract "Abstract High-grade serous ovarian cancers (HGSOC) represent the most common of the ovarian malignancies. Due to the frequency of late-stage diagnosis and high rates of recurrence following standard of care treatments, novel therapies are needed to promote durable responses. We investigated the anti-tumor activity of CD3 T cell-engaging bispecific antibodies (TCBs) directed against the PAX8 lineage-driven HGSOC tumor antigen LYPD1 and demonstrated that anti-LYPD1 TCBs induce T cell activation and promote in vivo tumor growth inhibition in LYPD1-expressing HGSOC. To selectively target LYPD1-expressing tumor cells with high expression while sparing cells with low expression, we coupled bivalent low-affinity anti-LYPD1 Fabs with the anti-CD3 SP34 scFv. In contrast to the monovalent anti-LYPD1 high-affinity TCB (VHP354), the bivalent low-affinity anti-LYPD1 TCB (QZC131) demonstrated antigen density-dependent selectivity and showed tolerability in cynomolgus monkeys at the maximum dose tested of 3 mpk. Collectively, these data demonstrate that bivalent TCBs directed against LYPD1 have compelling efficacy and safety profiles supportive of consideration for treatment of high-grade serous ovarian cancers." @default.
- W4253443458 created "2022-05-12" @default.
- W4253443458 creator A5001878157 @default.
- W4253443458 creator A5002672495 @default.
- W4253443458 creator A5007262835 @default.
- W4253443458 creator A5013669743 @default.
- W4253443458 creator A5014292133 @default.
- W4253443458 creator A5021771446 @default.
- W4253443458 creator A5022140329 @default.
- W4253443458 creator A5024832384 @default.
- W4253443458 creator A5025039860 @default.
- W4253443458 creator A5026920910 @default.
- W4253443458 creator A5028086031 @default.
- W4253443458 creator A5030855177 @default.
- W4253443458 creator A5032554982 @default.
- W4253443458 creator A5033700832 @default.
- W4253443458 creator A5046590612 @default.
- W4253443458 creator A5047177763 @default.
- W4253443458 creator A5052684337 @default.
- W4253443458 creator A5059420690 @default.
- W4253443458 creator A5061254688 @default.
- W4253443458 creator A5064284188 @default.
- W4253443458 creator A5064796958 @default.
- W4253443458 creator A5067173318 @default.
- W4253443458 creator A5067458821 @default.
- W4253443458 creator A5070697772 @default.
- W4253443458 creator A5070715132 @default.
- W4253443458 creator A5072359600 @default.
- W4253443458 creator A5072697946 @default.
- W4253443458 creator A5073935082 @default.
- W4253443458 creator A5080548120 @default.
- W4253443458 creator A5091759945 @default.
- W4253443458 date "2021-03-18" @default.
- W4253443458 modified "2023-10-16" @default.
- W4253443458 title "PAX8 lineage-driven T cell-engaging antibody for the treatment of high-grade serous ovarian cancer" @default.
- W4253443458 doi "https://doi.org/10.21203/rs.3.rs-295111/v1" @default.
- W4253443458 hasPublicationYear "2021" @default.
- W4253443458 type Work @default.
- W4253443458 citedByCount "0" @default.
- W4253443458 crossrefType "posted-content" @default.
- W4253443458 hasAuthorship W4253443458A5001878157 @default.
- W4253443458 hasAuthorship W4253443458A5002672495 @default.
- W4253443458 hasAuthorship W4253443458A5007262835 @default.
- W4253443458 hasAuthorship W4253443458A5013669743 @default.
- W4253443458 hasAuthorship W4253443458A5014292133 @default.
- W4253443458 hasAuthorship W4253443458A5021771446 @default.
- W4253443458 hasAuthorship W4253443458A5022140329 @default.
- W4253443458 hasAuthorship W4253443458A5024832384 @default.
- W4253443458 hasAuthorship W4253443458A5025039860 @default.
- W4253443458 hasAuthorship W4253443458A5026920910 @default.
- W4253443458 hasAuthorship W4253443458A5028086031 @default.
- W4253443458 hasAuthorship W4253443458A5030855177 @default.
- W4253443458 hasAuthorship W4253443458A5032554982 @default.
- W4253443458 hasAuthorship W4253443458A5033700832 @default.
- W4253443458 hasAuthorship W4253443458A5046590612 @default.
- W4253443458 hasAuthorship W4253443458A5047177763 @default.
- W4253443458 hasAuthorship W4253443458A5052684337 @default.
- W4253443458 hasAuthorship W4253443458A5059420690 @default.
- W4253443458 hasAuthorship W4253443458A5061254688 @default.
- W4253443458 hasAuthorship W4253443458A5064284188 @default.
- W4253443458 hasAuthorship W4253443458A5064796958 @default.
- W4253443458 hasAuthorship W4253443458A5067173318 @default.
- W4253443458 hasAuthorship W4253443458A5067458821 @default.
- W4253443458 hasAuthorship W4253443458A5070697772 @default.
- W4253443458 hasAuthorship W4253443458A5070715132 @default.
- W4253443458 hasAuthorship W4253443458A5072359600 @default.
- W4253443458 hasAuthorship W4253443458A5072697946 @default.
- W4253443458 hasAuthorship W4253443458A5073935082 @default.
- W4253443458 hasAuthorship W4253443458A5080548120 @default.
- W4253443458 hasAuthorship W4253443458A5091759945 @default.
- W4253443458 hasBestOaLocation W42534434581 @default.
- W4253443458 hasConcept C121608353 @default.
- W4253443458 hasConcept C126322002 @default.
- W4253443458 hasConcept C147483822 @default.
- W4253443458 hasConcept C150173356 @default.
- W4253443458 hasConcept C150903083 @default.
- W4253443458 hasConcept C159654299 @default.
- W4253443458 hasConcept C178790620 @default.
- W4253443458 hasConcept C185592680 @default.
- W4253443458 hasConcept C197934379 @default.
- W4253443458 hasConcept C203014093 @default.
- W4253443458 hasConcept C207001950 @default.
- W4253443458 hasConcept C2776620830 @default.
- W4253443458 hasConcept C2778375690 @default.
- W4253443458 hasConcept C2780427987 @default.
- W4253443458 hasConcept C502942594 @default.
- W4253443458 hasConcept C544153396 @default.
- W4253443458 hasConcept C71924100 @default.
- W4253443458 hasConcept C86803240 @default.
- W4253443458 hasConceptScore W4253443458C121608353 @default.
- W4253443458 hasConceptScore W4253443458C126322002 @default.
- W4253443458 hasConceptScore W4253443458C147483822 @default.
- W4253443458 hasConceptScore W4253443458C150173356 @default.
- W4253443458 hasConceptScore W4253443458C150903083 @default.
- W4253443458 hasConceptScore W4253443458C159654299 @default.
- W4253443458 hasConceptScore W4253443458C178790620 @default.
- W4253443458 hasConceptScore W4253443458C185592680 @default.
- W4253443458 hasConceptScore W4253443458C197934379 @default.
- W4253443458 hasConceptScore W4253443458C203014093 @default.
- W4253443458 hasConceptScore W4253443458C207001950 @default.